PRECISION BIOSCIENCES INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Precision Biosciences Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q2 2024.
  • Precision Biosciences Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.93M, a 24.4% decline year-over-year.
  • Precision Biosciences Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $11.9M, a 32.5% decline year-over-year.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 26.9% decline from 2022.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2022 was $19.2M, a 16.2% increase from 2021.
  • Precision Biosciences Inc annual Share-based Payment Arrangement, Expense for 2021 was $16.5M, a 19.8% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $11.9M $2.93M -$945K -24.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $12.9M $2.91M -$1.19M -29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $14M $2.97M -$1.57M -34.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $15.6M $3.11M -$2.03M -39.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $17.6M $3.87M -$1.26M -24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $18.9M $4.09M -$298K -6.79% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $19.2M $4.54M +$101K +2.28% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $19.1M $5.13M +$582K +12.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $18.5M $5.14M +$1.24M +31.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $17.3M $4.39M +$758K +20.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $16.5M $4.44M +$581K +15.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $15.9M $4.55M +$842K +22.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $15.1M $3.9M +$778K +25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $14.3M $3.63M +$527K +17% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $13.8M $3.85M +$1.23M +47% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $12.6M $3.71M +$1.22M +48.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $11.3M $3.12M +$839K +36.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $10.5M $3.11M +$1.56M +100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $8.94M $2.62M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.49M +$2.2M +753% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $2.28M +$2.02M +794% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.55M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $292K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $255K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.